Guest Speaker: Dr. Teitelbaum, MD, Effective Treatment of Fibromyalgia, Fatigue, and Pain

Dr. Teitelbaum, MD, Guest Speaker: Effective Treatment of Fibromyalgia, Fatigue, and Pain

Apr 26, 2017   9:00pm EDT   2 hours

 

Dr. Teitelbaum’s published research, and experience with effectively treating thousands of people with fibromyalgia, shows that 91% of people improve with an average 90% increase in quality of life. This is done by increasing energy production with the SHINE Protocol, which also results in the release of tight muscles. In addition, Dr. Teitelbaum will also discuss how to treat other kinds of pain, such as arthritis, neuropathies, migraines, etc., using the best of natural and prescription therapies.
Doing so, he finds that most pain can be effectively treated. He is the author of From Fatigued to Fantastic, the Fatigue and Fibromyalgia Solution, Pain Free 1-2-3, and the Cures A-Z Phone app.

NOTE AGAIN: All members will be able to speak directly to the doctor and ask questions.

Furthermore, Jacob Teitelbaum, M.D., is one of the most frequently quoted integrative medical authorities in the world. He is the author of the best-selling From Fatigued to Fantastic!, Pain Free, 1,2,3!, the Complete Guide to Beating Sugar Addiction, Real Cause Real Cure, The Fatigue and Fibromyalgia Solution, and the popular free Smart Phone app Cures A-Z. He is the lead author of 4 studies on effective treatment for fibromyalgia and chronic fatigue syndrome, and a study on effective treatment of autism using NAET. Dr. Teitelbaum appears often as a guest on news and talk shows nationwide including Good Morning America, The Dr. Oz Show, Oprah & Friends, CNN, and FoxNewsHealth

 

Register for meeting:   https://livesupportgroup.com/webinars/

1-ribbonFirst they came for the mentally ill addicts, and I did not speak out—
Because I was not a mentally ill addict.

Then they came for the empathetic prescribers, and I did not speak out—
Because I was not an empathetic prescriber.

Then they came for the Pharmacists, and I did not speak out—
Because I was not a Pharmacist.

Then they came for me—and there was no one left to speak for me

Form from a Part D provider…. how to file discrimination complaints

SEND LETTER TO POTUS

http://lettertodonaldtrump.com/search/node/mc%20con

What do you do… when you can’t tell the difference between the cops and the crooks ?

06cLUCASaDEA agent on trial, accused of working with lying informant to concoct bogus drug cases

http://www.cleveland.com/court-justice/index.ssf/2017/04/dea_agent_on_trial_accused_of.html

CLEVELAND, Ohio — Testimony in a civil trial began Tuesday for a U.S. Drug Enforcement Administration agent accused of misconduct in a series of botched cases in Mansfield that landed a man in prison for 18 months for a drug deal in which he did not participate.

Mansfield resident Joshawa Webb filed suit against agent Lee Lucas and others for a decade-old drug case in which he was charged.

The U.S. Attorney’s Office dropped the case against Webb in 2007, along with those of several other people ensnared in a federal crack-cocaine investigation known as Operation Turnaround. A paid informant named Jerrell Bray admitted to staging phone calls and identifying the wrong people when setting up drug deals on behalf of federal agents.

Lucas was indicted in 2009 and a jury acquitted him in 2010 on accusations that he lied on written reports and in court to corroborate Bray’s testimony. Webb’s lawsuit has been pending since 2007 and finally made it to trial this week after appeals and court battles. A jury was picked Monday.

Bray admitted in that he used his friend, Jeremiah Conrad, as a stand-in for Webb during a drug deal. Lucas posed as a drug user and took part in a controlled buy and later said Webb was the one who sold him the drugs, even though Conrad is noticeably shorter and leaner than Webb.

Jon Loevy, Webb’s attorney, said in his opening statements Tuesday that he is asking the jury to decide whether Bray was fooling the DEA or whether they knew and, at the very least, turned a blind eye. He said his client has never sold crack cocaine, though he has convictions for dealing marijuana and severely beating his stepfather.

“You can’t just lie to make drug cases. And that’s what happened in Operation Turnaround,” Loevy said.

He listed several reasons why the jury should not be swayed by any arguments Lucas might make that Bray fooled him, including accusations that Lucas concealed his informant’s own drug crimes.

Lucas maintains his innocence. His attorney Thomas Roth said Bray concocted his story to sidestep an attempted murder case in Cleveland at that time. 

Roth read from a transcript of Lucas’ criminal trial where Bray testified that he went to federal authorities because “I was trying to get myself out of trouble, so I was lying, sir.”

The attorney said Webb and Bray were friends. He also said Webb, at one point, admitted he was guilty of the drug conspiracy charge in his indictment.

“You can’t just lie to make drug cases. And that’s what happened in Operation Turnaround,” – Jon Loevy

 

Roth said that Loevy’s description of the DEA agent “is not the Lee Lucas I know.”

Webb is also suing retired Richland County Sheriff’s Office detective Charles Metcalf. Metcalf pleaded guilty in 2009 violating the civil rights of Dwayne Nabors, the owner of a car detail shop. He testified against Lucas at the agent’s criminal trial.

Michael Heimlich, an attorney representing Metcalf, said his client’s role was limited and that Metcalf was not involved in the drug deal that resulted in Webb’s arrest. He said the detective was on scene for backup in case anything happened.

Heimlich told the jury that Loevy has been careless with the facts of the case.

The trial could last for several weeks.

Lucas’ trial has been the talk of the federal courthouse this week, as many who worked with him still remember the burly career drug agent. He was heralded by his fellow law enforcement officers for having a tireless work ethic. During his time. He worked closely with the Cleveland police department’s narcotics unit.

Lucas was suspended for 45 days for failing to include all required information in reports in cases against two suspects.

Bray died in September 2012 at the age of 40, while he was in the middle of serving more than 13 years in prison for lying during the operation.

Herman Price, another man whose case was to be tried along with Webb’s, settled Monday with defendants in Richland County. Loevy, who also represented Price, refused to discuss the settlement terms, as did an attorney representing the Sheriff’s Office.

Richard County Sheriff’s Major Joe Masi referred a cleveland.com reporter to the attorney. When asked for a copy of the settlement agreement, he said the Sheriff’s Office doesn’t have one.

 

Judge rules in favor of Tennessee clinic in meningitis outbreak case

Judge rules in favor of Tennessee clinic in meningitis outbreak case

http://www.commercialappeal.com/story/life/health/2017/04/24/judge-rules-favor-tennessee-clinic-meningitis-outbreak-case/100867202/

A federal judge has ruled that the U.S. Food and Drug Administration and a state pharmacy board can be found at fault for the 2012 fungal meningitis outbreak that took the lives of some 77 patients who had been injected with fungus contaminated drugs.

In a nine-page ruling issued Monday, U.S. District Judge Rya Zobel concluded that lawyers for a Tennessee pain clinic had presented sufficient evidence in her Boston, Mass. courtroom for the claims that the two agencies acted recklessly to go forward.

Zobel denied a motion filed by attorneys for some 20 Tennessee victims of the outbreak to dismiss claims by the Specialty Surgery Center in Crossville, Tenn. that the government agencies could be found at fault for failure to take action against the New England Compounding Center, the maker of the deadly spinal steroids.

Citing a “special duty” provision of Tennessee’s comparative fault law, Zobel concluded that the clinic’s lawyers presented “sufficient assertions to state an affirmative defense of comparative fault” against the FDA and the Massachusetts Board of Pharmacy.

Under Tennessee law, Zobel’s ruling could clear the way for any damages awarded against the surgery center to be reduced by the percentage of fault found by a jury against the FDA and the Massachusetts board. However, the two agencies, who are not parties to the suit, could not be forced to pay anything to victims.

 Chris Tardio, one of the clinic lawyers, said the ruling means “we may present the jury with a full picture of how the meningitis outbreak occurred, including how it could have been prevented by those responsible for monitoring NECC’s activities.”

Noting that the ruling is only a preliminary one, a victims’ attorney expressed confidence in the ultimate outcome, adding “We are confident that “once we present this to the court on a full factual record that the court will find that the governmental agencies were not reckless.”

Zobel did dismiss parallel comparative fault claims against the Tennessee Health Department and the Tennessee Board of Pharmacy.

Zobel cited the claims by the surgery center lawyers that the FDA received numerous complaints that NECC was violating the FDA’s guidance on drug compounding but “nevertheless failed to take any subsequent action to address the serious nature of the complaints which proximately caused the alleged injuries.”

She noted that as early as 2002 the FDA was made aware of problems at NECC and four years later issued a warning letter but then failed to act.

“Defendants allege the FDA acted recklessly because it knew NECC had sterility and potency issues but failed to take any substantive action,” the ruling states.

As for the Massachusetts board, Zobel cited evidence presented by the clinic’s lawyers showing the the board “was aware of NECC’s failure to comply with applicable state and federal law and manufacturing guidelines, failed to inform other state pharmacy boards of  of the threat to public health caused by NECC’s non-public track record of regulatory noncompliance with state and federal law.”

In a footnote Zobel noted the November 2012 congressional testimony of then Massachusetts Health Commissioner Lauren Smith that the state pharmacy board’s failure to take decisive action against NECC in response to the 2006 complaints “has contributed to these tragic events.”

Man’s family sues doctors after fatal overdose

Man’s family sues doctors after fatal overdose

http://www.wpxi.com/news/top-stories/mans-family-sues-doctors-after-fatal-overdose/515967345

McKEESPORT, Pa. – The family of a McKeesport man is suing his doctors, claiming that they repeatedly gave him prescription painkillers despite knowing about his addiction.
 
Nicholas Classic died in October 2015 after overdosing on prescription drugs. He was 29.
According to a wrongful death lawsuit filed Tuesday in Allegheny County Court of Common Pleas, doctors at a McKeesport clinic prescribed Classic painkillers in March 2013 after an MRI showed a mild bulged disk in his back. 
 
Classic continued to receive pain medication for two years before the doctor wrote a note saying, in part: 
 
“Patient in the past few weeks has demonstrated overuse, urgency in wanting to obtain further quantity when overtaken and has called this office several times insistent on knowing when his medications would be prescribed.” 
 
Family members said Classic had a near fatal overdose less than a month later, but found other doctors to prescribe painkillers to him. The lawsuit alleges this patter continued until his fatal overdose in October 2015. 
The lawsuit was filed by Classic’s mother. Seven doctors and counselors are named as defendants.
 
“She had been waging an almost one-woman crusade to get these doctors to stop prescribing to her son,” said Alan Perer, the Classic family’s attorney. “She failed in her attempts to prevent this from happening to her son. She would like to see the system improve.” 
 
Channel 11 reached out to the seven doctors and counselors named in the lawsuit. All either declined to comment or did not return phone calls. 
 
The prescription drug monitoring program was not implemented until several months after Classic’s death. The program requires doctors to put patients getting prescription drugs into a shared system to prevent “doctor shopping.” 
Pennsylvania was one of the last states to implement a state wide drug database system… Only Missouri still does not have a state wide PMP.  Of course, back in 2005 Pres Bush (43) signed into law a NATIONAL prescription database http://nasper.org/  but Congress had never funded it operation.  So healthcare providers in PA were “flying blind”… but the bureaucracy will not take any responsible in this death, and who “forced” this man to take all those opiates ?  SEVEN DOCTORS… isn’t it illegal to obtain controlled substances for non-legit reasons.. Of course, you can charge someone who is DEAD for the illegal activity done while they were alive.. Couldn’t the parents had him arrested for this illegal activity… at least … he might still be around..

Jailing “drug dealers” will not prevent substance abusers from ODing.. FILL THE JAILS ?

NH treats overdoses as crime scenes, targets drug dealers

http://www.foxnews.com/us/2017/04/24/nh-treats-overdoses-as-crime-scenes-targets-drug-dealers.html

VIDEO ON LINK

Dakota Kilburn was just 23-years-old when a dose of heroin claimed his life. The young father was found unresponsive in his parent’s Manchester, Vermont home on November 18th, 2015.

His heartbroken parents remember a young man filled with potential until addiction took hold.

“He said ’till you do it you’ll never understand. It gets you, it holds onto you and all you ever do is want it,’” said Daniel Kilburn, Dakota’s father.

“He loved being outside, he loved singing loud, he loved playing with little kids,” said Maisie, Dakota’s mother. “He just enjoyed life. He really did.”

DRUG DEALERS WOULD FACE MANSLAUGHTER CHARGES FOR OPIOID OVERDOSES UNDER PROPOSED FLORIDA LAW

Intent on finding Dakota’s supplier, police followed the clues to neighboring New Hampshire where two men were charged under a statute that aims to hold those who sell drugs with a ‘death resulting’ responsible for the loss of life.

Francis Mayhle, 25, a childhood friend, was sentenced to a year in prison. Daniel Fogg, 27, who sold Mayhle the fatal drug, which he provided to Dakota, got 6 1/2 to 14 years.

“They are literally selling poison, killing people with that poison and for them, they need to face a punishment,” said Ben Agati, a senior assistant attorney general in New Hampshire. “They need to face some measure of justice.”

The previously little used-charge carries up to life in prison.

“We were dealing with just an influx of overdoses, overdose deaths, misery,” laments Jon DeLena, the Assistant Special Agent in Charge for the Drug Enforcement Administration, Manchester District.

DRUG DEALER CONVICTED OF MURDER IN FATAL FENTANYL SALE

Facing a rising death toll, hit hard by the opioid crisis wracking the nation, the DEA and the Attorney General’s office in New Hampshire and law-enforcement across the state have launched a collaborative program that trains officers and prosecutors to treat overdoses as crime scenes.

“The syringe has become the murder weapon,” DeLena said.

The approach is emerging as model for other efforts nationwide. It aims to ensure the right evidence is gathered, streamlines investigations and targets dealers whose actions claim so many lives.

“The first step is to try to figure out where this drug came from that killed this person and how do we quickly identify the source and take them off the street,” DeLena said.

A strike force was created to respond 24 hours a day, packed with experts, including a prosecutor and homicide detective.

“The homicide detective looks at this a little differently and slows things down, maybe would observe things differently than we would,” DeLena said.

Police officers on the scene of an overdose can call for advice or request additional manpower.

“We’re able to help advise them about what’s going to be usable at trial and what’s not,” Agati said.

A database helps to connect the dots.

“From a tragic overdose death scene to maybe two or three different cities in New Hampshire down into Massachusetts to a supplier down there,” said DeLena of the trail they often follow. “We’re able to arrest everybody that was involved along the chain that led to that person’s death.”

The approach has led to roughly a dozen “death resulting” prosecutions but some critics say aggressive arrests won’t curb the crisis.

“It’s going to end up saving absolutely no lives and result in millions or tens of millions of dollars being spent locking up drug dealers who will simply be replaced by other dealers,” argues Ethan Nadelmann of the Drug Policy Alliance, a New York based non-profit focused on reform efforts.

But the Granite State program is gaining nationwide attention from fellow prosecutors and investigators say they’ve heard, through cases they’re working, that traffickers are keenly aware of the efforts and are trying to avoid the Granite State.

“The abilities that we now have to investigate and hold people accountable are tremendous,” Agati said.

Daniel Kilburn, Dakota’s father, wants dealers to know they will face consequences.

“Too many of them,” Kilburn said, “are let go way too easily or with a slap on the wrist.”

DEA sells drugs to people on the streets with the goal of catching “bigger fish.”

DEA Just Admitted To Selling Drugs On Streets – Youth ‘Informants’ Forced To Help

www.countercurrentnews.com/2017/04/dea-just-admitted-to-selling-drugs-on-streets-youth-informants-forced-to-help/

The War on Drugs, carried out by the DEA, continues unabated since its establishment in the 1970s during the Nixon administration era.

For years, countless arrests have occurred, many of them for victimless crimes involving cannabis. Large sentences are dealt, some carrying hefty jail times.

Only this week, Canada unveiled their legislation to fully legalize cannabis, acknowledging the War on Drugs is fruitless. “We know that criminal prohibition has failed,” said former police chief turned MP Bill Blair. “Legalization seeks to regulate and restrict access to cannabis and will make Canada safer.”

 

But cannabis isn’t the topic for debate. Blair summoned up what is pertinent to the War on Drugs across every nation: that it has failed.

The hypocrisy that is the DEA’s refusal to acknowledge the medicinal benefits of cannabis cannot go unnoted; yet, more importantly,  they have been caught red-handed, admitting tacitly during a House Judiciary Committee Hearing that the DEA sells drugs to people on the streets with the goal of catching “bigger fish.”

The War on Drugs is perpetuated by the Drug Enforcement Agency who insists on locking people up for years at a time, for possession of what is still scheduled as a Class A substance, though now legal in many US states.

In the first week of April, the DEA was questioned over whether they allow shipments of drugs into the community for the sake of making a bigger bust down the track. The Washington Post reported on the transcript between Louisiana Democratic Rep. Cedric L. Richmond asking the DEA’s appointed acting director Chuck Rosenberg on the issue:

“RICHMOND: This committee held many hearings, and was furious about the Fast and Furious program. At least from my knowledge of DEA and other drug agencies, oftentimes part of a bigger sting is letting transactions and other things go through. Now, it’s a very specific question. In DEA’s past, present, future, any times do you let drugs hit communities to get the bigger fish?

ROSENBERG: We’re not supposed to, no, sir.

 

RICHMOND: Okay. Are you aware of any instances where it may happen?

ROSENBERG: I’ll have to check and get back to you on that.”

Although Rosenberg didn’t outright confirm it, he didn’t deny the allegation either. If he had, he would have perjured himself at the committee hearing.

The Washington Post notes Rosenberg’s unwillingness to be forthcoming unsurprising as there is “considerable evidence that DEA does allow drugs to enter communities in the hopes of bringing down major players in drug dealing and distribution.”

Eighteen months ago, the DEA was also criticized by the Department of Justice’s Inspector General for approving illegal activities of sources.

 

“These inadequate DEA policies and procedures related to OIA greatly increase the risk to the DEA, the U.S. government, and the public from the involvement of DEA confidential sources in OIA,” the audit report stated.

CBS’ 60 Minutes also covered a story about “confidential informants” – or many young college students getting “recruited” by law enforcement to carry out undercover drug buys “in exchange for having their charges reduced or dropped altogether.” Most of the charges stem from cannabis possession of small amounts.

“These kids are being recruited to do the most dangerous type of police work. They’re going undercover, with no background, training, or experience. They haven’t been to the police academy,” Lance Block, an attorney in Tallahassee, Florida told reporters.

Block became aware of the practice when Rachel Hoffman’s family hired him for representation. Hoffman was a college graduate on her second marijuana arrest when she became an informant. She signed on; otherwise facing a four year jail term, Hoffman was killed weeks later in a historic Tallahassee undercover buy involving an ounce and a half of cocaine and a gun.

“She was a pot head,” Block said. She had no experience in weapons or hard drugs.

Hoffman, monitored by 20 officers was forced to drive to a different location when the dealers changed plans. She was alone in her car with $13,000 cash from police to use in the deal. Hoffman was shot five times after the dealers discovered she had a wire on her. Her body was dumped in a ditch, Block said.

It’s a reminder of the DEA’s guilt. Although the agency refuses to release information pertaining to these sorts of deals with youth informants, experts say the DEA engages in the practice, selling drugs on the street.

Mutually Exclusive: politicians and COMMON SENSE ?

Are The Majority Of Drugs Coming From Mexico? Trump Says His Wall Will Stop It All

https://www.romper.com/p/are-the-majority-of-drugs-coming-from-mexico-trump-says-his-wall-will-stop-it-all-53228

 

Looks at the map of the USA… and who believes that building a wall along the few thousand miles between the USA and Mexico and it will solve our drug problem ?  Leaving the entire border along with Gulf of Mexico, the entire east coast, west coast and Canadian borders..There are BILLIONS of dollars in it for the various drug cartels.. they are just going to “give up” when/if the wall is built ? First it was making Oxycontin “abuse proof” and there was a shift to “street drugs”… then there was a tightening/restriction of legal opiates to both legal and bogus pts and now we are dealing with Heroin mixed with illegal Fentanyl analogs on the street and opiate OD’s are increasing exponentially and while numbers are not being released… but…we are spending an increasing fortune on Narcan/Naloxone reviving the same people over and over again… because … we revive them and send them back to the environment that facilitated them using/abusing various substances.

On Monday, the Associated Press released its transcript of its interview with President Donald Trump, who spoke about his first 100 days in office. Trump again spoke of his infamous wall, and how it will become a working monument to America’s war on drugs. “The wall will stop the drugs,” Trump told the AP’s White House correspondent Julie Pace on Friday, after noting that “drugs are pouring through on the southern border.” Are the majority of drugs coming from Mexico into the United States?

According to the U.S. Drug Enforcement Administration, much of the nation’s most used illicit drugs are actually coming from Mexico and other South American countries — but the drug crisis in American is far more complicated than just illicit border crossings and drug mules. While America’s opioid epidemic touches every corner of the country, it didn’t start at the U.S.-Mexico border — rather, it began in doctors’ offices and hospitals.

Abuse of prescription painkillers like OxyContin has often become a gateway to heroin. When the prescription runs out but the addiction remains, heroin is an alternative to circumvent increasing — and necessary — regulatory restrictions on prescription painkillers. Even though the drugs may be getting into the United States through its southern border, the problem starts long before Mexican drug cartels ever come into the picture.

CNN on YouTube

Between 2007 and 2013, the United States saw a 244 percent jump in heroin-related deaths, according to the Centers for Disease Control and Prevention. A February report from the CDC revealed that 25 percent of overdoses are from heroin. Nearly all of America’s heroin comes from Mexico and South America, according to the DEA. While heroin production is typically associated with the poppy fields of Afghanistan, the reality in 2017 is that 46 percent of America’s heroin now comes from Mexico, thanks in large part to Mexican drug cartels.

Likewise, most of America’s fentanyl comes from Mexico, according to the DEA. Fentanyl is a controlled pharmaceutical painkiller much like morphine, oxycodone, or hydrocodone — but is far more potent. In 2016, musician Prince accidentally overdosed on fentanyl; this type of death is not uncommon among people who abuse painkillers as they fail to realize just how potent and deadly fentanyl can be in small doses. Increasingly, law enforcement have found that batches of heroin have fentanyl “cut in” to the final product, creating regional spurts of fentanyl-laced heroin overdoses and deaths.

In addition to heroin and fentanyl, much of America’s methamphetamine, known as “meth” and “crystal meth,” also comes from Mexico — and not just from chemistry teachers’s vans in the New Mexico desert, as Breaking Bad would have you believe. But America’s meth labs — particularly in the Midwest — are certainly a homegrown problem as pervasive as illegally trafficked Mexican meth is invasive.

Giphy

While there’s no doubt that the majority of America’s most illicit drugs come from Mexico, building a wall will do little to stop drugs from “pouring through” the nation’s Mexican border. Trump’s argument is that a physical wall will somehow halt the entirety of the illegal Mexican-U.S. drug trade. While drug seizures at the U.S.-Mexico border are common, just how drugs come into the United States isn’t just limited to land crossings. As the DEA noted in its 2015 National Drug Threat Assessment Summary, drug smugglers are even using drones to send drugs into the country.

The wall could stop some of the drug traffic into the United States, but it certainly won’t stop all of it. Trump himself even noted that his wall might only stop as little as “1 percent of the drugs coming in,” as he told the AP Friday. Trump thinks his wall will only cost $10 billion, but a U.S. Department of Homeland Security internal report obtained by Reuters estimates Trump’s wall will cost more than $20 billion — and that’s an awful lot of money for a what amounts to a wide-mesh drug sieve rather than an airtight wall against drugs from Mexico.

truTV on YouTube

As much as Trump wants to put “America first,” he could learn a thing or two from Portugal and Uruguay. Portugal was the first European country to decriminalize drugs. Instead of seeing addicts as criminals, Portugal takes a rehabilitative approach. Uruguay legalized marijuana in 2013, taking the cue from other nations who focus on rehabilitation instead of criminalization. In both countries, the results have been astonishing: Portugal has the lowest drug use rates in Europe. Uruguay has managed to substantially undermine marijuana trafficking by allowing its government to sell a gram of marijuana for just $1; consumers are limited to 40 grams per month.

VICE on YouTube

It’s important to remember that decriminalization doesn’t mean you can pick up your dime bag of weed at your local grocer’s — but it’s the first step to changing the “culture of drugs” Trump repeatedly brings up when he justifies his wall. If America starts treating drug addiction as an illness instead of a crime, then there’s no need to build a wall. America’s war on drugs has failed. It’s time to stop investing in war and scare tactics and direct that money towards rehabilitation.

But Trump has already proven he won’t be the leader to take on that helm, when he advocated for a Republican health care bill that would have eliminated addiction treatment as an essential health benefit. For Trump, it’s all about making grand gestures in black and white — from his show-and-tell executive order signings to building a wall — but tackling America’s drug problem requires far more nuanced finesse than this administration has been able to demonstrate in its first 100 days.

Chronic Pain Patients’ Pain Management Survey

Chronic Pain Patients’ Pain Management Survey

Dr. Terri Lewis and I are reopening Chronic Pain Patients’ Pain Management Survey. It’s short and only takes a moment to complete. It’s only open till 8/4/17. Please complete (if you haven’t yet) and repost in every group you know, if you would please.

https://www.esurveycreator.com/s/1a5fb5a

Drug company close to paying $35 million settlement

Action 9: Drug company close to paying $35 million settlement

http://www.wsoctv.com/news/action-9/action-9-drug-company-close-to-paying-35-million-settlement/515653827

Some people might be entitled to a portion of a $35 million settlement. It is part of one of the biggest drug company settlements in U.S. history.

The Federal Trade Commission and multiple state attorneys general said the companies that made the popular sleep-disorder drug PROVIGIL — Cephalon Inc. and Teva Pharmaceutical Industries — illegally blocked competition. The government said the drug makers paid competitors more than $300 million not to make generics for six years.

The FTC went after the drug makers in 2008, and both sides settled in 2015. The drug companies didn’t admit wrongdoing, but agreed to pay $1.2 billion, including that $35 million for patients – patients like Mike Daisley. 

Daisley found out when he was 25 he had multiple sclerosis. He’s 61 now and a lawyer, which can be physically draining, especially with MS, so he uses PROVIGIL. 

“It helped me stay alert; helped me stay on top of my game,” he said.

But he said he would have taken a generic if he could have, and now Daisley wants in on that payout.

“I’m not anti-pharma. I’m not anti-drug manufacturer. I’ve benefited from that drug,” he told Action 9 investigator Jason Stoogenke. “But they ought to be fair about the business practices that they do, Jason. They ought not to engage in unfair competitive behavior.”

There are a lot of rules about who is eligible for a payout. Customers had to buy PROVIGIL between June 24, 2006, and March 31, 2012. Customers must file a claim by June 25.

CLICK HERE for details on filing a claim.

%d bloggers like this: